Leukapheresis Protocol

Leukapheresis Protocol

Es posible que algunos contenidos no estén disponibles en español.

Purpose of this Study

We are doing this study to support vaccine development by studying blood cells of the immune system.

Who Can Participate?

Eligibility

Adults who:
  • Are ages 18 - 60
  • Are in good health
  • Do not have a bleeding disorder
  • Are at least 110 pounds
  • Do not have an autoimmune disease(s)
  • Are not pregnant
  • Have not had cancer within the past 5 years
  • Are not currently in an investigational study
  • Are not taking medications to treat high blood pressure
If you need assistance in understanding if you can participate, please contact Luis Ballón at 919-620-5334 or Darren Morrow at 919-684-6043.

What is Involved?

Description

If you choose to join this study, you will have 2 visits.
  • You will have blood draws at both visits
  • The first visit will measure safety labs
  • The second visit will be 3 hours long for the leukapheresis procedure

Study Details

Full Title

EQA Proficiency Testing and Quality Control Leukapheresis Protocol

Principal Investigator

Thomas
Denny

Protocol Number

PRO00000873

Enrollment Status

Open to Enrollment